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west of Sydney, Australia. Of these, 2,901 participants (82.7%) provided fasting blood for estimates of 
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with very low serum vitamin B12 (<125 pmol/L) and low serum folate, 51% had elevated homocysteine. 
Conclusions: Low serum levels of vitamin B12 and elevated serum homocysteine are relatively frequent in 
older Australians. Implications: Appropriate public health action should be considered to reduce the 
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The prevalence of low blood levels offolate and vitamin B12 increases aspeople age.1 Low serum levels of
folate and vitamin B12 may lead potentially
to several poor health outcomes. Low folate
can cause gastrointestinal tract disturbances
and eventual megaloblastic anaemia. Low
vitamin B12 is of particular concern in the
elderly, because it can cause megaloblastic
anaemia and result in progressive
neuropathy.2 One of the most important
effects of low blood folate and vitamin B12,
however, is that this leads to elevated serum
homocysteine, which may possibly carry a
higher cardiovascular disease risk.3 Elevated
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serum homocysteine has also been linked to
other conditions affecting the elderly
including cognitive dysfunction4 and vascular
eye disease.5 Studies also indicate that
elevated serum homocysteine in older people
occurs at relatively higher serum vitamin B12
levels than in younger subjects,1,6 suggesting
that the cut-points used to identify a ‘low
level’ or deficiency state in older people may
need to be higher than cut-points used for
younger ages.
In recent years, folate fortif ication
of commonly consumed foods has been
introduced in several countries in order
to increase folate intakes in women of
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child-bearing age, since numerous studies have shown that higher
folate intake can prevent neonatal neural tube defects.7 However,
to determine the public health impact of folate fortification on
middle aged and older people, reliable prevalence estimates for
both vitamin B12 and folate deficiency are required.8 Recent
studies have been reported from United Kingdom, the Netherlands,
United States of America and New Zealand,1,6,9,10 with prevalence
estimates for vitamin B12 deficiency ranging from 10-40%,
depending on the method and cut-points used to determine
deficiency. No population-based studies of blood levels for folate,
vitamin B12 and homocysteine have been conducted in Australia.
We report data from a representative population of older
Australians to examine the prevalence of low serum folate and
vitamin B12 and their effects on serum homocysteine.
Methods
Study population
A population cohort of 3,654 residents aged 49 years or older,
living in two postcode areas of the Blue Mountains region, west
of Sydney, was surveyed during 1992-94 for the Blue Mountains
Eye Study (BMES1). The current study included 2,332 survivors
from the cohort seen in BMES1 (response 75%, after excluding
deaths) and a further 1,174 age-eligible residents not examined in
BMES1 who had moved to the area over the five-year period since
BMES1. These subjects had an age range of 50-98 years and were
examined during the period 1997-2000, with an overall response
of 83%. Of 3,508 total participants in the second cross-section,
2,963 provided blood for analysis (84.5%). This population had
similar characteristics to older Australians in general,11 with the
exceptions that participants in BMES were slightly older, were
more likely to have been born in the United Kingdom or Ireland
and had a slightly higher socio-economic status (home ownership
and higher educational level) than the Australian population of
similar age range.12
Blood assays
Participants returned for fasting blood tests following their eye
examinations, with biochemical estimations conducted at the
Institute of Clinical Pathology and Medical Research (ICPMR) at
Westmead Hospital. Serum vitamin B12, folate and red cell folate
assays were performed using the competitive-binding assay
method, conducted on a Beckman-Access analyzer. Total serum
homocysteine assays were derived using a fluorescence polarisation
immunoassay method on an IMx Analyzer. Serum folate, vitamin
B12 and serum homocysteine were performed in assays for 2,901
subjects, while red cell folate assays were performed on a
subsample of available fresh red cells (n=1,460). More details about
the laboratory methods used are available on request.
Because functional folate and vitamin B12 deficiency are not
well defined, and the vitamin B12 cut-off for the diagnosis of
deficiency in older people may need to be increased,1 we applied
a number of cut-points for serum vitamin B12: <125 pmol/L
(ICPMR laboratory guide), 125-<185 pmol/L,13 185-<220 pmol/
L14 and ≥220 pmol/L. Serum folate cut-points were: <6.8 nmol/L
(ICPMR lab guide), 6.8-<11 nmol/L,13,15 and ≥11 nmol/L. Cut-
points for red cell folate were: <370 nmol/L (ICPMR lab guide),
370-<513 nmol/L.16 Red cell folate was included because it may
be a better measure of long-term folate intake than serum folate.15
Statistical analyses
The proportion of persons with serum folate, serum vitamin
B12 and red cell folate at various cut-points were estimated and
those with elevated serum homocysteine (>15 µmol/L) are
indicated by each category. Significant differences between genders
were calculated using z-ratios. Figures present the proportion of
people considered as likely to be deficient or at risk of deficiency
in folate (red cell folate) or vitamin B12, by gender and age
categories (p for trend calculated using the Mantel-Haenszel chi-
square statistic). The maximum number for each table and figure
Table 1: Prevalence of various cut-points for low serum vitamin B12, serum folate and red cell folate, and proportion
who had elevated serum homocysteine (>15 μmol/L) in 2,901 older Australians.
Variable n (%) Homocysteine >15 μmol/L
(n, % of those in blood category)
Total Women Men Total Women Men
Serum vitamin B12 (pmol/L)
1. ‘very low’<125 184 (6.3) 101 (6.1) 83 (6.7) 95 (51.6) 44 (43.6) 51b (61.4)
2. ‘low’125-<185 481 (16.6) 263 (15.9) 218 (17.5) 124 (25.8) 59 (22.4) 65a (29.8)
3. ‘moderately low’185-<220 359 (12.4) 178 (10.8) 181b (14.5) 69 (19.2) 26 (14.6) 43a (23.8)
4. ‘normal’ ≥220 1,877 (64.7) 1,113 (67.2) 764b (61.3) 198 (10.5) 97 (8.7) 101b (13.2)
Serum folate (nmol/L)
1. ‘very low’<6.8 66 (2.3) 32 (1.9) 34 (2.7) 34 (51.5) 13 (40.6) 21a (61.8)
2. ‘moderately low’ 6.8-<11 471 (16.2) 255 (15.4) 216 (17.3) 176 (37.4) 92 (36.1) 84 (38.9)
3. ‘normal’ ≥11 2,364 (81.5) 1,367 (82.6) 997 (80)a 276 (11.7) 121 (8.9) 155b (15.5)
Red cell folate (nmol/L)
1. ‘very low’<370 20 (1.4) 12 (1.5) 8 (1.3) 13 (65) 6 (50) 7 (87.5)
2. ‘moderately low’ 370-<513 82 (5.8) 51 (6.5) 31 (4.5) 37 (45) 22 (43.1) 15 (48.4)
3. ‘normal’ ≥513 1,313 (92.8) 718 (91.9) 595 (93.8) 163 (12.4) 68 (9.5) 95 (16)b
Notes:
(a) p for significant difference by gender <0.05 (calculated using the z-ratio for significance of difference between independent proportion).
(b) p for significant difference by gender <0.01.
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is presented, so that subject number may vary between tables. All
analyses used SAS version 8.0 (SAS Institute, Inc. Cary, NC).
P-values <0.05 were considered statistically significant.
Results
Table 1 shows the prevalence of low B12 and folate using various
cut-points. Very low levels of serum vitamin B12, indicating
deficiency (<125 pmol/L) were observed in 6.3% of BMES
participants (6.1% of women and 6.7% of men). Low serum
vitamin B12 (<185 pmol/L) was present in 22.9% of persons
(22.0% of women and 24.2% of men), and 35.3% when moderately
low serum B12 level was defined as <220 pmol/L. Very low serum
folate (<6.8 nmol/L) was present in only 2.3% of persons in this
age range (2.0% of women and 2.7% of men), but 18.5% were
low using the higher cut-point of <11.0 nmol/L. Based on red cell
folate assays, 1.4% of persons (1.5% of women and 1.3% of men)
had very low levels of folate, indicating a high likelihood of folate
deficiency (<370 nmol/L) and 7.2% had moderately low folate
levels (<513 nmol/L). In persons with very low serum vitamin
B12 and very low serum folate, about 51% had elevated
homocysteine levels. In persons with very low and moderately
low red cell folate, approximately 65% and 45%, respectively, had
elevated homocysteine levels. Men were more likely to have
elevated serum homocysteine levels with very low concentrations
of serum vitamin B12 and serum folate (p=0.008, p=0.04,
respectively). Overall, elevated serum homocysteine (>15 µmol/
L) was found in 16.7% of participants (20.8% men and 13.7% of
women, p<0.0001) in this population.
The proportion of people with low serum vitamin B12 increased
with age as shown in Figure 1 and this trend was more marked in
men (p for trend in men ≤0.0001). Among persons aged 80 years
or older, 9.5% of women and 13.6% of men had very low serum
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Figure 1: Prevalence of low serum vitamin B12, by age
categories, in 1,690 women and 1,273 men. Vitamin B12
deficiency is likely for serum B12 <125 pmol/L; persons
are considered at risk of vitamin B12 deficiency for
serum B12 <185 pmol/L.
(*p for trend <0.05; **p for trend<0.001)
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Figure 2: Prevalence of low red cell folate, by age
categories, in 805 women and 655 men. Folate
deficiency is likely for red cell folate <370 nmol/L;
persons are considered at risk of folate deficiency for
red cell folate <513 nmol/L.
  (*p for trend <0.05; **p for trend <0.001)
B12, indicating a high likelihood of vitamin B12 deficiency.
Approximately 30% of men aged 70 years and over and women
aged 80 years and over had low serum B12 values, and were thus
at risk of vitamin B12 deficiency.
The prevalence of very low red cell folate increased with age
for both women and men, and the trend was particularly marked
for men (p for trend in men = 0.001), with the prevalence increasing
to 9.4% in men aged 80 years or older. Using a higher cut-point
(<513 nmol/L), relatively similar proportions of older men and
women were at risk of folate deficiency, rising with age to around
16% among persons aged 80 years or older.
Discussion
This study provides evidence that a relatively high proportion
of older Australians have low vitamin B12 levels (22.9%). Although
low blood folate levels were uncommon, the proportion with low
levels of folate increased with age, up to 10% among males 80
years and over. In addition, about half of those with very low serum
vitamin B12, very low serum folate and moderately low red cell
folate demonstrated a likelihood of having a functional deficiency,
as they had elevated serum homocysteine. Increased evidence
suggests that the measurement of serum methylmalonic acid
(MMA) and/or serum total homocysteine should be included in
the tools to diagnose vitamin B12 or folate deficiency,1,17,18
especially in cases of borderline concentrations. MMA is a more
expensive measure and therefore less practical to include in regular
clinical assessments. Overall, we found an elevated serum
homocysteine in a relatively high proportion (16.7%) of the study
population. This is an important finding, not only in terms of the
associated increased risk with vitamin B12 and folate deficiency,
but because it is a possible independent risk factor for vascular
disease.3
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In Australia, folate fortification of food is voluntary, and
breakfast cereals are the main products fortified. In previous
research,8 we examined the potential impact on folate intake in
older people if folate fortification became mandatory in Australia.
Under this scenario, our results showed that only 0.5% of the study
population would be likely to consume levels greater than 1000 µg
per day from synthetic folic acid, the intake considered by the
Institute of Medicine (IOM) as the tolerable upper intake level.19
Concern has been expressed in the literature that mandatory folate
fortification may adversely affect people with B12 deficiency by
masking the deficiency,20 although this risk is considered very low
if clinicians routinely diagnose B12 deficiency with appropriate
tests, including serum B12 levels and homocysteine.1 Evidence
concerning relevant clinical practice could not be located in the
literature, but the results of a recent United States (US) study of
the prevalence of megaloblastic anaemia before and after
mandatory folate fortification are reassuring. Although folate
fortification may be expected to reduce the prevalence of anaemia
in people with vitamin B12 deficiency, Mills and others (2003)21
observed no significant change in anaemia prevalence among
groups of older people with low serum B12 prior to and after
mandatory folate fortification was introduced. Because our study
suggests that a large proportion of older Australians could be at
risk of B12 deficiency, this should be considered in current
revisions to food regulations relating to food fortification. Some
researchers have suggested that vitamin B12 should be added to
any folate-fortified foods.22,23 Because our earlier research showed
that most older people who would be likely to consume high levels
of folate are those who take supplements containing folic acid,8 it
is recommended that vitamin B12 be included in any vitamin
supplements containing folate.
Consideration should also be given to identifying those older
people at risk of low serum vitamin B12 and elevated
homocysteine, among whom early intervention with the use of
appropriate supplements may be valuable. In a recent small
intervention trial, Bjorkegren (2004)18 observed an improvement
in not only haematological parameters but also neurological
symptoms (indicative of B12 deficiency) and oral mucosal
symptoms (indicative of folate deficiency), among older people
receiving folate and B12 supplements who had been identified
with low serum B12 and elevated homocysteine or MMA. Other
studies have shown no or little improvement in clinical symptoms
or health-related quality of life with lowering MMA or
homocysteine.24,25 These studies, however, were conducted on
younger adults.
This paper provides the first population-based data about the
status of folate, vitamin B12 and homocysteine levels among older
people in Australia. Of particular concern is the substantial pool
of older people at risk of vitamin B12 deficiency and the prevalence
of elevated serum homocysteine levels, for which evidence
indicates is an independent risk factor for vascular disease.3 An
understanding of the modif iable determinants of serum
homocysteine and serum vitamin B12 will be important in
determining future public health recommendations.
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